PG60(POM) Guideline on the perioperative management of patients with suspected or proven hypersensitivity to chlorhexidine

CP24 Policy for the development and review of professional documents 2024

New Zealand National Committee feedback on experiences during and lessons learned from the COVID-19 pandemic.

The purpose of this document is to support fellows and other CPD participants completing the ANZCA and FPM CPD Program under the clinical practice type.

PG27(A)BP Guideline for major extracorporeal perfusion Background Paper

PS41(G)BP Position statement on acute pain management Background Paper

ANZCA and FPM are accredited by the Australian Medical Council (AMC) and Medical Council of New Zealand (MCNZ) to deliver our training programs, SIMG assessment process and continuing professional development program. We submit yearly reports against the AMC and MCNZ accredita...